Cellenkosinc
An early stage clinical biotechnology company that focuses on umbilical cord blood derived T-regulatory cellular therapies.
Employees
Enterprise value
$60—90m
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.